Breaking News
July 19, 2018 - Deleting single gene in gut bacteria affects metabolism, reduces weight gain in mice
July 19, 2018 - Study finds major discrepancies in prescription drug labeling pregnancy information across four countries
July 19, 2018 - Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for Treatment of Ewing’s Sarcoma
July 19, 2018 - Watching the immune system in action reveals what happens when things goes wrong
July 19, 2018 - Increasing blood sugar levels improves memory and performance in older adults
July 19, 2018 - Connection between self-regulation and obesity appears to be different for girls and boys
July 19, 2018 - Researchers develop new, less destructive method for whitening teeth
July 19, 2018 - Revving up innate control of viral infection requires a three-cell ignition
July 19, 2018 - Inaccurate direct-to-consumer raw genetic data can harm patients, new research suggests
July 19, 2018 - Weight loss surgery is effective under the right situations
July 19, 2018 - BioTek awarded patent for autofocus feature on microplate reader
July 19, 2018 - Low-carb diets reduce stiffness of arteries in women and promote weight loss in men
July 19, 2018 - New review examines cannabinoids’ potential for direct treatment of cancer
July 19, 2018 - Allergic responses may help protect the skin against cancer, research suggests
July 19, 2018 - Inappropriate Prescribing of Abx High in Urgent Care Centers
July 19, 2018 - Many at risk for HIV despite lifesaving pill
July 19, 2018 - Tips for doctors and parents on the harms of marijuana use for teens
July 18, 2018 - Researchers detect presence of IgE antibodies after kidney transplantation
July 18, 2018 - New technique allows researchers to create large scale, personalized bone grafts
July 18, 2018 - Smoking May Boost Atrial Fibrillation Risk
July 18, 2018 - Genome editing method targets AIDS virus
July 18, 2018 - These things matter: Medical complications are not inevitable, a physician writes
July 18, 2018 - Cognitive functions often wilt as water departs the body, shows study
July 18, 2018 - Origins of bread found 14,400 years ago in Jordan
July 18, 2018 - Low-dose ketamine found to be as effective as opioids for treating acute pain
July 18, 2018 - Novel bioengineering technique could help repair bone defects
July 18, 2018 - Researchers identify new potential target protein for colon cancer
July 18, 2018 - Air pollution contributes significantly to diabetes globally
July 18, 2018 - Cell membrane’s importance offers new strategy to fight infections
July 18, 2018 - Researchers identify key protein involved in irregular brain cell activity
July 18, 2018 - 3D modeling of drug resistance could lead to more effective cancer treatment
July 18, 2018 - Hunger hormones could be key to new treatments for drug, alcohol addiction
July 18, 2018 - Nitrate-cured meats may contribute to mania, study finds
July 18, 2018 - Why men may recover more quickly from influenza infections than women
July 18, 2018 - Study finds discharge against medical advice as predictor of readmissions in heart attack patients
July 18, 2018 - KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
July 18, 2018 - Self-control and obesity: Gender matters in children
July 18, 2018 - Bioengineers, diabetes researchers convene to discuss future concepts for precision medicine
July 18, 2018 - New findings support more conservative use of ED neuroimaging for non-index seizures
July 18, 2018 - Practicing yoga benefits pregnant women, study suggests
July 18, 2018 - New strategy may lead to more accurate breast cancer diagnoses
July 18, 2018 - FDA Approves Symtuza (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
July 18, 2018 - New guide helps hospitals pick right partner to handle hospitalist services
July 18, 2018 - Deep data dive helps predict cerebral palsy
July 18, 2018 - Stricter firearm legislation associated with reduced murder and suicide rates
July 18, 2018 - Physical and sexual abuse in childhood associated with endometriosis risk
July 18, 2018 - Omega 3 supplements do not reduce risk of heart disease, stroke or death
July 18, 2018 - GSA’s new publication provides support for safe use of OTC analgesics by older adults
July 18, 2018 - Researchers receive grant from U.S. Department of Education to study children with HFASD
July 18, 2018 - Early childhood adversity increases sensitivity of the body’s immune response to cocaine
July 18, 2018 - Parental incarceration affects health behaviors of children in adulthood
July 18, 2018 - Researchers find that yellow fever and Asian tiger mosquitoes can carry new virus
July 18, 2018 - Two Regimens Fail to Stop Declines in β-Cell Function
July 18, 2018 - Researchers apply computing power to track the spread of cancer
July 18, 2018 - Olfactory receptors play pathophysiological role in all organs than merely smell perception
July 18, 2018 - Fish consumption associated with lower risk of early death
July 18, 2018 - MR Solutions’ 7T MRI imaging system installed at University of Hawaii
July 18, 2018 - Humorous ads screened around World Cup game achieve higher biometric response than sporty ads
July 18, 2018 - New study demonstrates little effect of hormone therapy on artery thickness
July 18, 2018 - A 3-Pronged Plan to Cut Type 2 Diabetes Risk
July 18, 2018 - New clues to sepsis may speed diagnosis
July 18, 2018 - Stars of Stanford Medicine: Improving cardiovascular health in Africa and beyond
July 18, 2018 - Heart attack risk continues to increase among pregnant women, study finds
July 18, 2018 - Few tips to help avoid sunburns in summer
July 18, 2018 - High-fat diet and systemic inflammation contribute to progression of prostate cancer
July 18, 2018 - Researchers develop 3D map of gene interactions that play key role in heart disease
July 18, 2018 - Conservative management of lung subsolid nodules reduces overtreatment and unnecessary surgery
July 18, 2018 - Report warns of dog illness that can spread to owners
July 18, 2018 - A winning essayist’s tips for keeping track of scientific facts
July 18, 2018 - Researchers seek to understand role of APOE mutation in Alzheimer’s disease
July 18, 2018 - Animal studies reveal brain changes responsible for appetite effects of cannabis
July 18, 2018 - New ZEISS ZEN Intellesis machine allows segmentation of correlative microscopy
July 18, 2018 - Study findings highlight importance of early detection of SMA through newborn screening
July 18, 2018 - Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of Pixuvri (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
July 18, 2018 - Diabetes researchers find switch for fatty liver disease
July 18, 2018 - The future of the microbiome: A conversation
July 18, 2018 - States attacking ACA would hurt most if shield on preexisting conditions were axed
July 18, 2018 - Novel delivery system for bacteriophages could offer new way to battle lung infections
July 18, 2018 - PTSD may increase risk of stroke, heart attack in World Trade Center response crews
July 18, 2018 - Finding the right protective eyewear for young athletes
Faulty Flu Shots? Blame Eggs

Faulty Flu Shots? Blame Eggs

image_pdfDownload PDFimage_print

People grumble a lot about the shortcomings of the flu vaccine, which some years offers less protection than expected. (Warning: This year may be one of them.) What they may not know is that the source of at least some of the problems is a common item found in all grocery stores and many fridges: the egg.

The overwhelming majority of flu vaccines are made from viruses grown in eggs. This production process is inexpensive and time-tested; flu vaccines have been made this way as long as flu vaccines have been made.

But the process is not ideal — and it leads to issues that can undermine the vaccine’s effectiveness. Increasingly, experts are questioning whether the pros of egg production are worth putting up with the cons.

“We need to do a lot to improve existing vaccines. And getting away from eggs would be very valuable,” said Kanta Subbarao, MD, director of the World Health Organization’s influenza collaborating center in Australia.

To produce flu vaccine, most manufacturers must grow lots of flu viruses, which are later killed or weakened before they are put into the vaccine. In all but a few cases, those viruses are grown in hens’ eggs.

But flu viruses must mutate — adapt — to grow inside eggs. Sometimes those mutations aren’t huge or aren’t on important spots on the virus and they don’t undermine the effectiveness of the vaccine. But when they are, the impact can be substantial. It’s as if the antibodies the vaccine generates are looking for Superman — but they encounter Clark Kent. The glasses, the suit, the tie confuse them; the antibodies don’t see Superman and the mild-mannered newsman as the same person and they don’t respond.

Researchers have known for a while that this can happen. In a study released on Monday, scientists said the disappointing performance of the vaccine last year was the result of a mutation that developed when the viruses for the vaccine were grown in eggs. The upshot: The antibodies generated by the H3N2 vaccine didn’t adequately target the viruses that were making people sick.

The H3N2 component in this year’s flu vaccine is identical to the one in last winter’s, so the vaccine could fail to provide strong protection again if H3N2 flu viruses are in high circulation this winter.

“To make a prediction about this flu season, it does appear if H3s do circulate, there will be this problem of this egg mutation,” said Scott Hensley, an associate microbiology professor at the University of Pennsylvania and senior author of the study, which was published in the Proceedings of the National Academy of Sciences.

Moving out of egg-based production would improve the performance of the vaccine, many experts believe.

Officially, the CDC doesn’t have a preference for how the flu vaccine is made — as long as the resulting product is safe and effective. But if you ask Daniel Jernigan, MD, MPH, director of the CDC’s influenza division, if eggs are the future of flu vaccines, his answer is telling.

“If you were to start now with a new vaccine for flu, would it be grown in eggs? No,” Jernigan said.

The U.S. government office charged with preparing the country to deal with public health emergencies like flu pandemics has recognized the limitations of egg-based flu vaccine production for a while. For more than a decade, BARDA — the Biomedical Advanced Research and Development Authority — has been working with manufacturers to encourage them to move some portion of production out of eggs.

Its funding helped foster development of the two flu vaccines on the market that aren’t made in eggs — FluBlok, a recombinant vaccine developed by Protein Sciences (recently acquired by Sanofi Pasteur) and Flucelvax, produced in the U.S. by the Australian company Seqirus.

The former is made of influenza hemagglutinin proteins — the main target of flu vaccines — that are generated by viruses that infect insect cells, while the latter is made of flu viruses grown in dog kidney cell lines.

Any time flu viruses have to adapt to grow in the cells of a new host — as in the case of the dog kidney cells — there can be mutations. But the egg-induced mutations seem more problematic. “I think historically just what we know about putting flu viruses in cells versus putting them in eggs is that generally the stability of the sequence is greater in mammalian cells,” said Jacqueline Katz, deputy director of CDC’s influenza division.

Producing too much of the nation’s flu vaccine supply in a single medium is literally as dangerous as putting all your eggs in one basket — especially given that some of the flu viruses that threaten to cause pandemics, such as H5N1 and H7N9, infect chickens, either killing them or reducing egg production.

“When I look at a need to produce 600 million doses of influenza vaccine in a very short timeline of a pandemic, it’s going to be really important that we have all horses in the race. So eggs and cells and recombinant,” said BARDA Director Rick Bright.

“Some [flu viruses] might grow well in eggs and some well in cells, and some better in recombinant systems,” he said. “So that’s been part of our strategy to make more capacity available domestically and also to diversify this for the various unpredictable attributes of influenza.”

There are a few key hurdles for those interested in seeing more seasonal production move out of eggs. The first is that there isn’t much evidence yet that the vaccines produced in other mediums perform better than those made in eggs. Experts believe the FluBlok and Flucelvax may be more effective against H3N2 viruses this winter than the egg-based vaccines, but companies won’t be motivated to make what would be a very expensive production shift on belief alone.

In fact, some companies that had been working on cell culture flu vaccines abandoned the work. “There wasn’t convincing evidence that it was better so why would anyone spend extra money to buy that?” noted John Treanor, MD, a flu vaccine expert at the University of Rochester.

“The business case was tough, and I think a lot of these enterprises did not make it partially because of that.”

To be clear, it’s not that these vaccines have been shown to be less effective or no more effective than vaccines produced in eggs. It’s that proof that they are better is sparse to date.

Researchers in the U.S., Canada, and parts of Europe conduct studies every year that estimate how effective the flu vaccine was at preventing illness. But those studies are not enormous and most of the people in them would be getting flu vaccine produced in eggs, so teasing out an answer from that research may not be possible.

Manufacturers themselves could study the question, and in a very crowded flu vaccine market may actually have motivation to do so. The CDC’s Jernigan noted that a few years back Sanofi Pasteur, the largest supplier of the flu vaccine, funded a trial that compared a high-dose formulation it wanted to sell to seniors against its regular vaccine. The high-dose vaccine was found to be more effective, and the company is allowed to target individuals 65 and older, the demographic most likely to get flu shots.

Studies that show convincingly that flu vaccines produced in cell culture or using other non-egg methods are better could lead the expert panel that counsels the CDC on vaccines, the Advisory Committee on Immunization Practices, to preferentially recommend those vaccines over vaccines produced in eggs.

“I think that kind of pressure — if there are preferential recommendations related to that — will drive change in industry,” said Danuta Skowronski, MD, an influenza expert at the British Columbia Center for Disease Control and lead author of a study that showed an egg-mutation problem in the 2012-2013 flu season.

Others aren’t so sure the industry would be willing to make a major production shift, which would require manufacturers to conduct expensive trials, apply for new regulatory licenses, and build and certify new production facilities.

“It’s a pretty big manufacturing lift. Or at least regulatory lift,” Jernigan said.

The other hurdle is the fact that many in industry, government, and public health have their eyes on a bigger prize. Rather than a small change that might offer modest improvements to the performance of flu vaccines, they’re looking to a radical shift — a flu vaccine that offers long-term protection against most or all known flu viruses. It’s the Holy Grail of flu, the so-called universal vaccine.

“In some ways, the whole discussion now about universal or game-changing vaccine has somewhat shifted the landscape. Because now people are going to say, ‘Wait a minute. Am I going to invest in an intermediate stage of vaccine production … and do this kind of fix on the current vaccine as an intermediate stage or interim stage?'” said Michael Osterholm, PhD, MPH, director of the Center for Infectious Diseases Research and Policy at the University of Minnesota.

“This is where you’re talking about the business of vaccines as much as you are the science. The business of the vaccine has been in part why we haven’t seen the science further along. Everybody felt like they had a nice business model going with what they had.”

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. She also covers global health.

This post originally appeared on STAT News.

2017-11-07T15:30:00-0500

Tagged with:

About author

Related Articles